Zoetis Inc. (ZTS) Declares Quarterly Dividend of $0.10
Zoetis Inc. (NYSE:ZTS) announced a quarterly dividend on Friday, October 7th. Stockholders of record on Thursday, November 3rd will be paid a dividend of 0.095 per share on Thursday, December 1st. This represents a $0.38 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Tuesday, November 1st.
Shares of Zoetis (NYSE:ZTS) traded up 0.39% during mid-day trading on Friday, hitting $51.85. The stock had a trading volume of 3,323,648 shares. Zoetis has a 12 month low of $38.26 and a 12 month high of $52.64. The stock’s 50-day moving average is $51.26 and its 200 day moving average is $48.67. The company has a market cap of $25.67 billion, a PE ratio of 40.38 and a beta of 1.01.
Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.44 by $0.05. The business earned $1.20 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Zoetis had a return on equity of 77.58% and a net margin of 13.15%. The business’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.43 earnings per share. On average, equities research analysts forecast that Zoetis will post $1.91 earnings per share for the current fiscal year.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/07/zoetis-inc-zts-declares-quarterly-dividend-of-0-10.html
A number of analysts have commented on ZTS shares. Jefferies Group restated a “buy” rating and issued a $60.00 price target on shares of Zoetis in a research report on Wednesday, September 14th. Bank of America Corp. started coverage on Zoetis in a research report on Thursday, September 29th. They issued a “buy” rating and a $60.00 price target for the company. Guggenheim restated a “positive” rating and issued a $60.00 price target on shares of Zoetis in a research report on Monday, August 22nd. Zacks Investment Research upgraded Zoetis from a “hold” rating to a “buy” rating and set a $53.00 price target for the company in a research report on Wednesday, June 15th. Finally, Citigroup Inc. upped their price target on Zoetis from $50.00 to $53.00 and gave the stock a “neutral” rating in a research report on Thursday, August 4th. Two research analysts have rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $55.27.
In other news, insider Heidi C. Chen sold 32,097 shares of the firm’s stock in a transaction that occurred on Thursday, September 1st. The stock was sold at an average price of $50.98, for a total value of $1,636,305.06. Following the completion of the sale, the insider now directly owns 46,060 shares of the company’s stock, valued at approximately $2,348,138.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Andrew Fenton sold 13,870 shares of the firm’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $51.25, for a total value of $710,837.50. Following the completion of the sale, the insider now directly owns 17,719 shares of the company’s stock, valued at $908,098.75. The disclosure for this sale can be found here. 0.05% of the stock is owned by insiders.
Several large investors have recently bought and sold shares of ZTS. Marshall Wace LLP raised its stake in Zoetis by 1.9% in the second quarter. Marshall Wace LLP now owns 9,159,978 shares of the company’s stock valued at $434,733,000 after buying an additional 173,902 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Zoetis by 114.1% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,738,248 shares of the company’s stock valued at $414,717,000 after buying an additional 4,656,765 shares during the last quarter. TIAA CREF Investment Management LLC raised its stake in Zoetis by 12.5% in the second quarter. TIAA CREF Investment Management LLC now owns 6,860,664 shares of the company’s stock valued at $325,607,000 after buying an additional 764,884 shares during the last quarter. American Century Companies Inc. raised its stake in Zoetis by 2.5% in the second quarter. American Century Companies Inc. now owns 4,140,302 shares of the company’s stock valued at $196,499,000 after buying an additional 102,941 shares during the last quarter. Finally, BlackRock Group LTD raised its stake in Zoetis by 0.4% in the second quarter. BlackRock Group LTD now owns 4,026,693 shares of the company’s stock valued at $191,106,000 after buying an additional 14,046 shares during the last quarter. 93.12% of the stock is owned by institutional investors and hedge funds.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.